Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy

Data on 16 potential risk factors for myelosuppression were assessed in 134 patients who received either vindesine and cisplatin (VP) or mitomycin C, vindesine and cisplatin (MVP) for inoperable stage III or IV non‐small cell lung cancer in a randomized trial. Determinant factors for myelosuppressio...

全面介紹

Na minha lista:
書目詳細資料
發表在:Jpn J Cancer Res
Main Authors: Matsui, Kaoru, Masuda, Noriyuki, Uchida, Yasuo, Fukuoka, Masahiro, Negoro, Shunichi, Yana, Takashi, Kusunoki, Yoko, Kudoh, Shinzoh, Kawase, Ichiro, Kawahara, Masaaki, Ogawara, Mitsumasa, Kodama, Nagahisa, Kubota, Kaoru, Furuse, Kiyoyuki
格式: Artigo
語言:Inglês
出版: Blackwell Publishing Ltd 1996
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5921149/
https://ncbi.nlm.nih.gov/pubmed/8698630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1996.tb00292.x
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍